secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0001493152-25-010875
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 5.03, 3.03, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve Series B conversion price cut to $1.50 and 2022 equity plan expansion
--------------------------------------------------------------------------------

- Series B Preferred conversion price reduced to $1.50 (from $2.25); floor price removed; dividend rights eliminated.
- 2022 Equity Incentive Plan amended: share reserve 10M shares, evergreen up to 2M shares/yr, max 26M shares.
- Stockholders approved issuance of Mango & Peaches subsidiary shares to CEO Jacob Cohen under Nasdaq Rule 5635.
- All four proposals approved at March 17, 2025 special meeting; Proposal 1 received 98.8% common and 100% Series B votes.
- Designation Amendment filed with Texas Secretary of State on March 17, 2025, effective upon stockholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225010875/0001493152-25-010875-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225010875/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-010875

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer